Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
The tumor suppressor p53 is degraded by the ubiquitin‐proteasome system. p53 was polyubiquitinated in the presence of E1, UbcH5 as E2 and MDM2 oncoprotein. A ubiquitin molecule bound MDM2 through sulfhydroxy bond which is characteristic of ubiquitin ligase (E3)‐ubiquitin binding. The cysteine residue in the carboxyl terminus of MDM2 was essential for the activity. These data suggest that the MDM2 protein, which is induced by p53, functions as a ubiquitin ligase, E3, in human papillomavirus‐uninfected cells which do not have E6 protein.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In undamaged cells, p53 protein levels are maintained at minimal levels due to prompt proteasome-targeting polyubiquitination by the Mdm2 E3 ubiquitin ligase (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997).”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Honda et al., 1997
In the citing paper
“Mdm2 is an E3 ubiquitin ligase that ubiquitylates and targets p53 for degradation (Haupt, et al., 1997; Honda, et al., 1997; Kubbutat, et al., 1997).”
From The Mdm network and its regulation of p53 activities: a rheostat of cancer risk (2014) · cites this paper as Honda, et al., 1997
In the citing paper
“Mdm2 is a RING-type E3 ubiquitin ligase (Honda et al., 1997;Fang et al., 2000;Honda and Yasuda, 2000), which directs the ubiquitylation of itself and p53.”
From Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms (2001) · cites this paper as Honda et al., 1997
In the citing paper
“For Mdm2 to ubiquitylate p53 its RING finger is essential (Honda et al., 1997).”
From Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms (2001) · cites this paper as Honda et al., 1997
In the citing paper
“MDM2 binds the p53 transactivation domain, leading to the inhibition of p53 function, nuclear export and degradation under physiological conditions.”
From Advances in targeted degradation of endogenous proteins (2019) · cites this paper as [65]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,054
Amplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949
The p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801
The ubiquitin-proteasome proteolytic pathway
Ciechanover, A. (1994) · Cell · doi:10.1016/0092-8674(94)90396-4 · Cited by 1,791
Research works printed but not linked: 2
- Maki C.G., 1996, Cancer Res., 56, 2649
- Funabiki H. Yamano H. Nagao K. Tanaka H. Yasuda H. Hunt T. and Yanagida M. (1997) EMBO J. in press.
Cited by
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N., Brennan, C., et al. (2007) · Genes & Development · doi:10.1101/gad.1596707 · Cited by 2,316
“…cell line, and then later found to be a key negative regulator of p53 during normal development and in tumorigenesis (Fakharzadeh et al. 1991; Momand et al. 1992; Oliner et al. 1993; Jones et al. 1995; Montes de Oca Luna et al. 1995; Honda et al. 1997; Fang et al. 2000; Honda and Yasuda 2000).”
BackgroundThe first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967
Kastenhuber, E. R., & Lowe, S. W. (2017) · Cell · doi:10.1016/j.cell.2017.08.028 · Cited by 1,906
Kruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610
The complexity of p53 modulation: emerging patterns from divergent signals
Giaccia, A. J., & Kastan, M. B. (1998) · Genes & Development · doi:10.1101/gad.12.19.2973 · Cited by 1,314
“Recent studies have implicated the Mdm2 protein as a major intracellular regulator of ubiquitin-mediated degradation of p53 protein (Haupt et al. 1997; Honda et al. 1997; Kubbutat et al. 1997; Midgley and Lane 1997).”
Background
Metadata
- Authors
- Honda, R., Tanaka, H., & Yasuda, H.
- Affiliations
- Tokyo University of Pharmacy and Life Sciences (JP)
- Corresponding author
- Yasuda, Hideyo
- ORCID
- Tanaka, Hirofumi
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 1997-12-22
- Volume
- 420
- Issue
- 1
- Pages
- 25-27
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W2007249806
- Cited by
- 1,951
- References
- 28
- Citations by year
- 2026: 28 · 2025: 40 · 2024: 40 · 2023: 46 · 2022: 60 · 2021: 50 · 2020: 75 · 2019: 55 · 2018: 52 · 2017: 55 · 2016: 75 · 2015: 57 · 2014: 102 · 2013: 68 · 2012: 82
- FWCI
- 22.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- FEBS Letters (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- MDM2, p53, E3 ubiquitin ligase, ubiquitin-proteasome system, protein degradation, polyubiquitination, cysteine residues, tumor suppressor
- MeSH terms
- Amino Acid Sequence, Cell Extracts, HeLa Cells, Humans, Ligases, Molecular Sequence Data, Nuclear Proteins, Proto-Oncogene Proteins, Ubiquitins, Tumor Suppressor Protein p53, Sequence Analysis, Ubiquitin-Conjugating Enzymes, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. https://app.cochat.ai/papers/10.1016/s0014-5793(97)01480-4
- The paper
- Honda, R., Tanaka, H., & Yasuda, H. (1997). Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Letters. https://doi.org/10.1016/s0014-5793(97)01480-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.